MARVELD1 and glioblastoma: Therefore, we analyzed the TCGA database and found that the patients with high MARVELD1 expression performed poorer overall survival among nine tumor types (including LGG, LUAD, STAD, GBM, ACC, BRCA, BLCA, LIHC and COAD) (Supplementary Fig. S1f).